
The Smartest Doctor in the Room
Ep. 243 - Dr. Richard Horowitz’s New Book on Ending Chronic Illness
Dr. Richard Horowitz reports the first published case of reversing P-tau 217, the most sensitive and specific Alzheimer's biomarker, in a live patient using a nine-week oral dapsone combination protocol, lowering it by 63% compared to the 23% reduction seen over six to seven years with anti-amyloid drugs like lecanemab. Author of the upcoming book Ending Chronic Illness, Dr. Horowitz breaks down his 16-point MSIDS model linking chronic Lyme disease, Bartonella, mold toxicity, and biofilm-persistent infections to Alzheimer's, long COVID, chronic fatigue syndrome, fibromyalgia, and autoimmune disease. He and Dr. Dean Mitchell also cover how to take a proper differential diagnosis history, why dapsone blocks the NLRP3 inflammasome pathway driving brain inflammation, and practical tick-bite prevention with picaridin and permethrin-treated clothing. Social Media: LinkedIn: linkedin.com/in/richard-horowitz-b4634012 Facebook: facebook.com/drrichardhorowitz Instagram: @drrichardhorowitz Websites: Book (Ending Chronic Illness): cangetbetter.com/ending-chronic-illness Primary site: cangetbetter.com Resources / Book Links: Medical Detective Substack: medicaldetective.substack.com Dapsone documentary (2024): DrTalks: Discover Healing 18 - Dapsone Testimonials Contact Dr. Mitchell: Email: care@mitchellmedicalgroup.com Website Instagram YouTube Facebook LinkedIn Book: Conquering Candida ImmunoLytics - code SmartestDoc, 5% off Apollo Neuro - code SMARTMD

